Brooks Moore & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$1.6M |
| 2 |
Oracle
ORCL
|
+$928K |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$921K |
| 4 |
Alibaba
BABA
|
+$468K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$403K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$1.19M |
| 2 |
Cisco
CSCO
|
+$743K |
| 3 |
Pfizer
PFE
|
+$609K |
| 4 |
IBM
IBM
|
+$606K |
| 5 |
Procter & Gamble
PG
|
+$420K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.28% |
| 2 | Technology | 15.46% |
| 3 | Consumer Staples | 14.87% |
| 4 | Industrials | 11.63% |
| 5 | Financials | 10.99% |
Similar funds
Brooks Moore & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Brooks Moore & Associates held 87 positions worth $145M, up 9.9% from $132M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Brooks Moore & Associates's Q4 2023 filing shows 8 new, 23 increased, 31 reduced and 1 closed positions. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 11,925 shares worth $969K. The largest sale was Vanguard International High Dividend Yield ETF, an estimated $1.19M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Staples.
- Brooks Moore & Associates's largest Q4 2023 buy was Vanguard Intermediate-Term Corporate Bond ETF: 11,925 shares worth $969K.
- Brooks Moore & Associates added most to Coca-Cola in Q4 2023, an estimated $1.6M increase.
- Brooks Moore & Associates's biggest Q4 2023 reduction was Vanguard International High Dividend Yield ETF, cutting an estimated $1.19M.
- Brooks Moore & Associates fully exited Pfizer in Q4 2023, selling an estimated $609K.
- Brooks Moore & Associates's ten largest holdings make up 36% of its $145M portfolio in Q4 2023.
- Brooks Moore & Associates opened 8 new positions and closed 1 in Q4 2023.
- Brooks Moore & Associates's portfolio value rose 9.9% quarter-over-quarter to $145M.
Based on Brooks Moore & Associates's 13F filing for Q4 2023, filed 15 Feb 2024.